NO20063865L - Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments - Google Patents

Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments

Info

Publication number
NO20063865L
NO20063865L NO20063865A NO20063865A NO20063865L NO 20063865 L NO20063865 L NO 20063865L NO 20063865 A NO20063865 A NO 20063865A NO 20063865 A NO20063865 A NO 20063865A NO 20063865 L NO20063865 L NO 20063865L
Authority
NO
Norway
Prior art keywords
quinolone
medicaments
amino
carboxylic acid
acid derivatives
Prior art date
Application number
NO20063865A
Other languages
Norwegian (no)
Inventor
Andreas Herling
Elisabeth Defossa
Thomas Klabunde
Karl-Ulrich Wendt
Dieter Kadereit
Sven Ruf
Dieter Schmoll
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20063865L publication Critical patent/NO20063865L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention relates to heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives as well as their physiologically compatible salts and physiologically functional derivatives. The invention concerns compounds of formula (I), wherein the radicals have the cited meanings, and the physiologically compatible salts thereof. The compounds are suited for use, e.g. as medicaments for preventing and treating type 2 diabetes.
NO20063865A 2004-01-31 2006-08-30 Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments NO20063865L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004004972A DE102004004972B3 (en) 2004-01-31 2004-01-31 Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
PCT/EP2005/000372 WO2005073230A1 (en) 2004-01-31 2005-01-15 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments

Publications (1)

Publication Number Publication Date
NO20063865L true NO20063865L (en) 2006-08-30

Family

ID=34813071

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063865A NO20063865L (en) 2004-01-31 2006-08-30 Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments

Country Status (16)

Country Link
EP (1) EP1720870B1 (en)
JP (1) JP2007519650A (en)
KR (1) KR20060129350A (en)
CN (1) CN1910181A (en)
AT (1) ATE370949T1 (en)
AU (1) AU2005209367A1 (en)
BR (1) BRPI0507313A (en)
CA (1) CA2554525A1 (en)
DE (2) DE102004004972B3 (en)
ES (1) ES2288292T3 (en)
IL (1) IL176914A0 (en)
MA (1) MA28339A1 (en)
NO (1) NO20063865L (en)
PT (1) PT1720870E (en)
RU (1) RU2006131308A (en)
WO (1) WO2005073230A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20110235A1 (en) 2006-05-04 2011-04-14 Boehringer Ingelheim Int PHARMACEUTICAL COMBINATIONS INCLUDING LINAGLIPTIN AND METMORPHINE
EP2540722B1 (en) 2006-10-16 2016-06-08 Bionomics Limited Novel anxiolytic compounds
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
KR100916161B1 (en) * 2007-02-21 2009-09-08 (주)바이오버드 Inhibitors to Proliferation of Smooth Muscle Cells
US20120093917A1 (en) * 2009-04-02 2012-04-19 Robert Hromas Metnase and intnase inhibitors and their use in treating cancer
CN101654435B (en) * 2009-06-09 2014-01-29 沈阳药科大学 N-benzyl quinoline carboxylic acid compound, combination and preparation method thereof
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
JP2014510065A (en) 2011-03-02 2014-04-24 バイオノミックス リミテッド Novel small molecules as therapeutic agents
US9133188B2 (en) 2011-05-12 2015-09-15 Bionomics Limited Methods for preparing naphthyridines
CN103183676B (en) * 2013-03-12 2015-04-08 中国医学科学院医药生物技术研究所 A group of 1-substituted-1, 8-naphthyridine formamide derivatives and preparation and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827600A1 (en) * 2001-07-20 2003-01-24 Lipha New quinolone acid derivatives with aldose reductase inhibiting activity, useful for prevention and treatment of diabetes-related disorders
GB0205162D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
CA2554525A1 (en) 2005-08-11
EP1720870A1 (en) 2006-11-15
DE102004004972B3 (en) 2005-09-15
PT1720870E (en) 2007-09-12
BRPI0507313A (en) 2007-06-26
JP2007519650A (en) 2007-07-19
CN1910181A (en) 2007-02-07
DE502005001315D1 (en) 2007-10-04
MA28339A1 (en) 2006-12-01
KR20060129350A (en) 2006-12-15
RU2006131308A (en) 2008-03-10
IL176914A0 (en) 2006-12-10
EP1720870B1 (en) 2007-08-22
AU2005209367A1 (en) 2005-08-11
WO2005073230A1 (en) 2005-08-11
ES2288292T3 (en) 2008-01-01
ATE370949T1 (en) 2007-09-15

Similar Documents

Publication Publication Date Title
NO20063865L (en) Heterocyclic substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
NO20080675L (en) P38-Map kinase inhibitors and methods for their use
NO20081482L (en) Delta and epsilon crystal forms for imatinib mesylate
NO20091599L (en) Chemical connections
NO20091596L (en) Benzoylamino Heterocyclic Compounds as Glucokinase (GLK) Activators
NO20053748L (en) Pyrrolopyridazine derivatives.
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
NO20050088L (en) Cationically substituted diphenylazofidinones, processes for their preparation, medicaments containing said compounds, and use thereof
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
NO20085060L (en) Triazole pyrazine derivatives useful as anti-cancer agents
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
NO20085068L (en) Phenylamino-benzoxazole-substituted carboxylic acids, process for their preparation and use thereof as medicaments
TW200635878A (en) Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use
NO20070089L (en) DPP-IV inhibitors
NO20050134L (en) Diphenyllazidide ions substituted with acid groups, process for their preparation, drugs containing these compounds and their use
NO20063859L (en) Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and use thereof as medicaments
NO20082496L (en) pyrazine derivatives
TW200616985A (en) Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
NO20080394L (en) N- (arylalkyl) -1H-pyrrolopyridine-2-carboxamide derivatives, preparation and use thereof
RS20060015A (en) Substituted thiazole- benzoisothiazole dioxide derivatives, method for the production thereof and use of the same
NO20060718L (en) Substituted thiophones and their use
ATE438617T1 (en) SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES
NO20054418L (en) Substituted benzoylureidopyridylpiperidine and pyrrolidinecarboxylic acid derivatives, their preparation and use
NO20053876D0 (en) Carbonylamino-substituted acylphenylurea derivatives, process for their preparation and use thereof
NO20081195L (en) Imidazopyridine derivatives as cannabinoid receptor ligands

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application